ALFA Filings
Every announcement, straight from the exchange
Every Gland Pharma business update announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Gland Pharma reports that USFDA concluded an unannounced cGMP inspection at its Dundigal formulation facility with four procedural Form 483 observations. No monetary impact is stated, and corrective actions will be submitted within the stipulated period.
Gland Pharma announced that the USFDA completed a routine GMP inspection of its Visakhapatnam facility with zero Form 483 observations.
Gland Pharma signed a strategic CDMO manufacturing agreement with a global pharmaceutical company. The partnership has an annualized revenue potential of approximately ₹855-950 Crore.
Gland Pharma signed a manufacturing and supply agreement with a global partner for sterile injectables. The partnership targets revenue from 2029 with 55 initial SKUs.